2023-03-24 09:24:02
Latest Post
W S Industries India Ltd approves availing of short term loans
SBI completes acquisition of 40% stake of Canara Bank in Commercial Indo Bank LLC
Indigenous Casting Technology Pvt Ltd becomes 100% subsidiary of NIBE Ltd
R.P.P Infra Projects Wins a New Order Worth INR 104.79 Crores
Healthcare Triangle to Participate in ViVE 2023 as Presenter and Sponsor
Stock Report
Emmessar Biotech and Nutrition Ltd Q3 FY23 loss at Rs. 2.20 lakhs
Posted On : 2023-02-04 18:32:55( TIMEZONE : IST )
EMMESSAR BIOTECH & NUTRITION LTD. has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 0.8721 crores during the period ended December 31, 2022 as compared to Rs. 0.4998 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. -0.0220 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 0.1349 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. -0.04 for the period ended December 31, 2022 as compared to Rs. 0.27 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹0.8721 crs | ₹0.4998 crs |  74.49% |
| Net Profit | ₹-0.0220 crs | ₹0.1349 crs |  -116.31% |
| EPS | ₹-0.04 | ₹0.27 | -114.81% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.0.8721 crores during the period ended December 31, 2022 as compared to Rs.0.5670 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-0.0220 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.0.1692 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.-0.04 for the period ended December 31, 2022 as compared to Rs.0.34 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹0.8721 crs | ₹0.5670 crs | 53.81% |
| Net Profit | ₹-0.0220 crs | ₹0.1692 crs | -113.00% |
| EPS | ₹-0.04 | ₹0.34 | -111.76% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.2.0207 crores during the 9 Months period ended December 31, 2022 as compared to Rs.1.4312 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.3081 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.0.4407 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.0.62 for the 9 Months period ended December 31, 2022 as compared to Rs.0.88 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹2.0207 crs | ₹1.4312 crs | 41.19% |
| Net Profit | ₹0.3081 crs | ₹0.4407 crs | -30.09% |
| EPS | ₹0.62 | ₹0.88 | -29.55% |
Shares of EMMESSAR BIOTECH & NUTRITION LTD. was last trading in BSE at Rs. 23.40 as compared to the previous close of Rs. 23.25. The total number of shares traded during the day was 6366 in over 41 trades.
The stock hit an intraday high of Rs. 24.20 and intraday low of 22.00. The net turnover during the day was Rs. 143037.00.
